Free Trial

Neuren Pharmaceuticals (NURPF) Short Interest Ratio & Short Volume

C$8.45 0.00 (0.00%)
(As of 11/7/2024 ET)

Neuren Pharmaceuticals Short Interest Data

Neuren Pharmaceuticals (NURPF) has a short interest of 1.94 million shares. This marks a -1.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2,429.5, indicating that it would take 2,429.5 days of the average trading volume of 3,219 shares to cover all short positions.

Current Short Interest
1,943,600 shares
Previous Short Interest
1,982,100 shares
Change Vs. Previous Month
-1.94%
Dollar Volume Sold Short
$12.85 million
Short Interest Ratio
2,429.5 Days to Cover
Last Record Date
October 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
3,219 shares
Today's Volume Vs. Average
0%
Short Selling Neuren Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NURPF Short Interest Over Time

NURPF Days to Cover Over Time

NURPF Percentage of Float Shorted Over Time

Neuren Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/20241,943,600 shares C$12.85 million -1.9%N/A2429.5 $6.61
9/30/20241,982,100 shares C$20.48 million -0.5%N/A19821 $10.33
9/15/20241,992,800 shares C$18.49 million +0.3%N/A2846.9 $9.28
8/31/20241,987,900 shares C$20.28 million -0.4%N/A1987.9 $10.20
8/15/20241,996,300 shares C$21.96 million +17.4%N/A570.4 $11.00
7/31/20241,700,300 shares C$24.23 million +0.2%N/A17003 $14.25
7/15/20241,697,200 shares C$24.19 million +2.4%N/A16972 $14.25
6/30/20241,657,900 shares C$23.63 million +2.9%N/A1657.9 $14.25
6/15/20241,610,900 shares C$20.30 million +0.6%N/A8054.5 $12.60
5/31/20241,601,800 shares C$21.62 million +2.7%N/A1232.2 $13.50
5/15/20241,559,200 shares C$21.14 million +12.9%N/A5197.3 $13.56
4/30/20241,380,500 shares C$17.27 million +16.6%N/A6902.5 $12.51
4/15/20241,184,100 shares C$14.84 million -0.2%N/A2960.3 $12.53
3/31/20241,187,000 shares C$15.97 million +0.3%N/A11870 $13.45
3/15/20241,183,900 shares C$16.57 million +0.1%N/A5919.5 $14.00
2/29/20241,183,000 shares C$14.20 million +0.4%N/A514.3 $12.00
2/15/20241,178,500 shares C$17.51 million +25.2%N/A41.8 $14.86
1/15/2024496,400 shares C$7.68 million +4,036.7%N/A551.6 $15.47
12/31/202312,000 shares C$203,760.00 +36.4%N/A9.4 $16.98
12/15/20238,800 shares C$97,328.00 -6.4%N/A4.9 $11.06
11/30/20239,400 shares C$93,718.00 -7.8%N/A23.5 $9.97
11/15/202310,200 shares C$91,800.00 -1.0%N/A4.6 $9.00
10/31/202310,300 shares C$67,980.00 +2.0%N/A11.4 $6.60
10/15/202310,100 shares C$73,730.00 No ChangeN/A14.4 $7.30
9/30/202310,100 shares C$74,336.00 -44.8%N/A1.2 $7.36
9/15/202318,300 shares C$134,871.00 -39.2%N/A45.8 $7.37
8/31/202330,100 shares C$254,194.50 -17.1%N/A1.3 $8.45
8/15/202336,300 shares C$286,407.00 -0.8%N/A9.6 $7.89
7/31/202336,600 shares C$350,262.00 +2.8%N/A91.5 $9.57
7/15/202335,600 shares C$327,520.00 +3,136.4%N/A178 $9.20
6/30/20231,100 shares C$8,800.00 -50.0%N/A2.2 $8.00
6/15/20232,200 shares C$19,492.00 +214.3%N/A0.8 $8.86
5/31/2023700 shares C$6,195.00 +250.0%N/A7 $8.85
5/15/2023200 shares C$1,850.00 No ChangeN/A2 $9.25
4/30/2023200 shares C$1,886.00 -33.3%N/A0.5 $9.43
4/15/2023300 shares C$2,682.00 +200.0%N/A1.5 $8.94
3/31/2023100 shares C$911.79 -95.2%N/A0 $9.12
3/15/20232,100 shares C$16,390.50 -66.7%N/A1.1 $7.81
2/28/20236,300 shares C$30,366.00 +215.0%N/A0.4 $4.82
2/15/20232,000 shares C$9,960.20 +150.0%N/A1.3 $4.98
The centerpiece of Trump’s crypto’s masterplan … (Ad)

Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”

Click here to find out more about what could be Trump and JD Vance’s favorite coin.
1/31/2023800 shares C$4,392.00 +300.0%N/A0.2 $5.49
1/15/2023200 shares C$1,227.00 No ChangeN/A2 $6.14
12/30/2022200 shares C$1,090.00 -50.0%N/A0 $5.45
12/15/2022400 shares C$1,966.00 -89.2%N/A0.5 $4.92
11/30/20223,700 shares C$20,331.50 +15.6%N/A7.4 $5.50
11/15/20223,200 shares C$18,016.00 +14.3%N/A6.4 $5.63
10/31/20222,800 shares C$13,440.00 -3.5%N/A0.1 $4.80
10/15/20222,900 shares C$12,035.00 -9.4%N/A9.7 $4.15
9/30/20223,200 shares C$13,696.00 +45.5%N/A5.3 $4.28
9/15/20222,200 shares C$9,900.00 +266.7%N/A0.1 $4.50
8/31/2022600 shares C$2,472.00 -73.9%N/A0.8 $4.12
8/15/20222,300 shares C$9,200.00 No ChangeN/A0.2 $4.00
6/30/2022400 shares C$1,040.00 -86.7%N/A4 $2.60
6/15/20223,000 shares C$0.00 +25.0%N/A30 $0.00

NURPF Short Interest - Frequently Asked Questions

What is Neuren Pharmaceuticals' current short interest?

Short interest is the volume of Neuren Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,943,600 shares of NURPF short. Learn More on Neuren Pharmaceuticals' current short interest.

What is a good short interest ratio for Neuren Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NURPF shares currently have a short interest ratio of 2,430.0. Learn More on Neuren Pharmaceuticals's short interest ratio.

Is Neuren Pharmaceuticals' short interest increasing or decreasing?

Neuren Pharmaceuticals saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 1,943,600 shares, a decrease of 1.9% from the previous total of 1,982,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Neuren Pharmaceuticals stock?

Short selling NURPF is an investing strategy that aims to generate trading profit from Neuren Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Neuren Pharmaceuticals?

A short squeeze for Neuren Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NURPF, which in turn drives the price of the stock up even further.

How often is Neuren Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NURPF, twice per month. The most recent reporting period available is October, 15 2024.




This page (OTCMKTS:NURPF) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners